August 30, 2007—Philips Medical Systems, Andover, Mass, and the Institute of Health Sciences (IHS) yesterday announced an agreement to establish a joint research laboratory within the IHS in Shanghai, China. The IHS is part of the Shanghai Institutes for Biological Sciences (SIBS) and is also affiliated to the Shanghai Jiao Tong University School of Medicine. The joint laboratory will conduct advanced research in the field of molecular medicine.

Philips and the IHS have signed a Memorandum of Understanding for a joint molecular medicine research program. The ultimate aim is to create new solutions for the early diagnosis of disease and for monitoring the effectiveness of subsequent treatment. Early diagnosis and personalized treatment will lead to increased comfort and better outcomes for patients. As part of this unique collaboration, Philips intends to locate a team of its own scientists at the joint research laboratory.

“This agreement to set up a joint research laboratory with the IHS in China is a prime example of the Open Innovation approach that Philips is taking in order to bring the many benefits of molecular medicine into patient care.” says Rick Harwig, CTO of Royal Philips Electronics. “As an international company with an ambition to provide healthcare solutions that are tailored to local needs, we are delighted to be partnering with a Chinese institute that within the space of a few years has become renowned for its life sciences research.”